National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

Denosumab May Help Prevent Bone Loss

Past Highlights
 
 
Results: 1 -10 of 16    Show     results per page
View Search Criteria | Help With Results
Title 
Phase sort descending
Protocol IDs 
 
Palifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE)

   
Phase III

   
20040212
NCT00109031

 
 
Phase III of Unilateral Neck Irradiation With Amifostine in Patients With SCC of the Head and Neck

   
Phase III

   
186-03
ETH136-03D, NCT00206752

 
 
Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation

   
Phase II

   
MCW-HRRC-28600
MCW-CHW-0070, NCI-V02-1699, NCT00036712

 
 
Etanercept Mouthwash to Treat Stomatitis and Oral Pain in Patients Receiving Chemotherapy

   
Phase II

   
020133
02-NR-0133, NCT00031551

 
 
Cox-2 Inhibition in Radiation-Induced Oral Mucositis

   
Phase II

   
IRB 03 -157- 2
GCRC 487, Pfizer, Inc.: COXAON-0509-150, NCT00698204

 
 
Effect of AdhAQP1 on Salivary Flow in Patients Treated With Radiation for Head and Neck Cancer

   
Phase I

   
060206
06-D-0206, NCT00372320

 
 
Melphalan and Palifermin in Treating Patients Undergoing An Autologous Peripheral Stem Cell Transplant for Stage II or III Multiple Myeloma

   
Phase I

   
WSU-2006-119
WSU 2006-119, NCT00482846

 
 
A Trial of Homeopathic Medication TRAUMEEL S for the Treatment of Radiation-Induced Mucositis

   
Phase I

   
TRAUMEEL_S_Krempl
NCT00584597

 
 
Comparing Over-the-Counter Dry Mouth Remedies After Radiation

   
Phase I

   
Dry Mouth_Krempl
IRB # 12518, NCT00595933

 
 
Dose Escalation Study Of Palifermin in Pediatric Research Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

   
Phase I

   
PALSCT
NCT00701688

 
      1 2   Next >

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov